| CAK | CDK-activating kinase |
| CDK7 | Cyclin-dependent kinase 7 |
| CI | Confidence interval |
| DAB | 3,3’-diaminobenzidine |
| DFS | Disease-free survival |
| DM | Distant metastasis |
| DSIF | DRB-sensitivity-inducing factor |
| FFPE | Formalin-fixed paraffin-embedded |
| HNSCC | Head and neck squamous-cell cancer |
| HPV | Human papilloma virus |
| HR | Hazard ratio |
| IHC | Immunhistochemistry |
| LN | Lymph node metastasis |
| MAPK-ERK | MAP-kinase |
| NELF | Negative elongation factor |
| NR | Nuclear receptor |
| NSCLC | Non-small-cell lung cancer |
| OS | Overall survival |
| PCC | Pearson correlation coefficient |
| PD-L1 | Programmed death ligand 1 |
| pMED1 | Phospho-mediator of RNA polymerase II transcription subunit 1 |
| PT | Primary tumor |
| RD | Recurrence |
| RNA Pol II | RNA polymerase II |
| ROI | Region of interest |
| SE | Super-enhancer |
| TMA | Tissue microarray |
| TPS | Tumor proportion score |
| UICC | Union internationale contre le cancer |